Clinical Trials Browser

Phase 2/3 × Asian Colorectal Cancer Patients × regorafenib × Clear all

NCT01189903 2014-01-28

Clinical Evaluation - A Phase IIA Proof of Concept Study of Regorafenib (Bayer 73-4506) in Biopsy-amenable Asian Colorectal Cancer Patients

Phase 2/3 Unknown

Gastrointestinal

Asian Colorectal Cancer Patients